IntegriChain, a Philadelphia, PA-based healthcare technology company delivering a comprehensive data and analytics platform covering all core elements of pharmaceutical product access, acquired Medical Communication Technologies, Inc., a provider of government pricing and contracting software and services.
The amount of the deal was not disclosed.
IntegriChain will integrate MCT’s government pricing SaaS platform into its ICyte data platform, creating an improved offering for bio/pharma manufacturers.
This acquisition adds 35+ new brand and generic bio/pharma manufacturer customers to IntegriChain’s 100+ customer base.
Led by Co-Founder and CEO Kevin Leininger and backed by Accel-KKR, IntegriChain is a healthcare technology company for bio/pharma manufacturers, employing data science to integrate all core elements of access data to deliver analytics and insights that help patients start and stay on therapy.
Its comprehensive commercial access data and analytics platform produces insights on bio/pharma therapies throughout their market life, from the launch of new innovative therapies to service-oriented channel models for mature product categories.
Led by Randy Perry, President, Medical Communication Technologies is a provider of government pricing and contracting software and services committed to meeting the strategic challenges encountered by bio/pharma manufacturers during the key phases of product commercialization. Founded in 2000, MCT provides strategic reimbursement planning and patient services as well as commercial payer/PBM and government contracting initiatives including government pricing services; government and commercial rebate processing; commercialization and distribution planning including 3PL and specialty pharmacy selection; trade relations; and patient coupon rebate processing.